Christof Vulsteke unpaid guest prof.

Publications Christof Vulsteke

Cisplatin- or carboplatin-based chemotherapy plus pembrolizumab in advanced urothelial cancer : exploratory analysis from the phase 3 KEYNOTE-361 study

Source
Clinical Genitourinary Cancer - ISSN 1558-7673-23:1 (2025) p. 1-11
Author(s)
    Thomas Powles, Tibor Csoszi, Yohann Loriot, Nobuaki Matsubara, Lajos Geczi, Susanna Y.-S Cheng, Yves Fradet, Ajjai Alva, Stephane Oudard, Christof Vulsteke, Rafael Morales-Barrera, Aude Flechon, Seyda Gunduz, Chih-Chin Liu, Blanca Homet Moreno, Abhishek Bavle, Mustafa Ozgueroglu

Association of tumor mutational burden and PD-L1 with the efficacy of pembrolizumab with or without chemotherapy versus chemotherapy in advanced urothelial carcinoma

Source
Clinical cancer research - ISSN 1078-0432-30:23 (2024) p. 5353-5364
Author(s)
    Aude Flechon, Rafael Morales-Barrera, Thomas Powles, Ajjai Alva, Mustafa Ozguroglu, Tibor Csoszi, Yohann Loriot, Alejo Rodriguez-Vida, Lajos Geczi, Susanna Y. Cheng, Yves Fradet, Stephane Oudard, Christof Vulsteke, Seyda Gunduz, Ronac Mamtani, Evan Y. Yu, Alvaro Montesa Pino, Urbano Anido, Mehmet A.N. Sendur, Gwenaelle Gravis, Janos Revesz, Vladimir Kostorov, Olivier Huillard, Junshui Ma, Mohini Rajasagi, Amir Vajdi, Jared Lunceford, Razvan Cristescu, Kentaro Imai, Blanca Homet Moreno, Nobuaki Matsubara

Niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer : final overall survival results from the PRIMA/ ENGOT-OV26/GOG-3012 trial

Source
Annals of oncology - ISSN 0923-7534-35:11 (2024) p. 981-992
Author(s)
    B.J. Monk, M.P. Barretina-Ginesta, B. Pothuri, I. Vergote, W. Graybill, M.R. Mirza, C.C. Mccormicky, D. Lorusso, R.G. Moore, G. Freyer, R.E. O'Cearbhaill, F. Heitz, D.M. O'Malley, A. Redondo, M.S. Shahin, Christof Vulsteke, W.H. Bradley, C.A. Haslund, D.M. Chase, C. Pisano, L.L. Holman, M.J. Rubio Perez, P. Disilvestro, L. Gaba, T.J. Herzog, I. Bruchim, N. Compton, L. Shtessel, I.A. Malinowska, A. Gonzalez-Martin

Meta-analysis of genome-wide association studies for cancer therapy-related cardiovascular dysfunction and functional mapping highlight an intergenic region close to TP63

Source
Scientific reports - ISSN 2045-2322-14:1 (2024) p. 1-10
Author(s)
    L. Martinez-Campelo, A. Blanco-Verea, T. Lopez-Fernandez, A. Martinez-Monzonis, A. Buno, P. Mazon, P. Zamora, N. Norton, J.S. Reddy, A. Velasco-Ruiz, A. Gonzalez-Neira, Christof Vulsteke, T. Alonso-Gordoa, R. Cruz, S. Diz-de Almeida, A. Carracedo, JR. Gonzalez-Juanatey, J. Lopez-Sendon, M. Brion